- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Estrogen Receptor- Negative Breast Cancer
Total 11844 results
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 and other conditionsUnited States
-
Institut Claudius RegaudActive, not recruitingTriple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mmFrance
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Joseph SparanoRecruitingBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
First Affiliated Hospital of Zhejiang UniversityShanghai Longfine Biotechnology Co., Ltd.; TopAllianceNot yet recruitingTriple-negative Breast CancerChina
-
Priyanka SharmaBristol-Myers Squibb; Celgene CorporationActive, not recruitingBreast Cancer | Triple-Negative Breast CancerUnited States
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Yonsei UniversityNot yet recruitingTNBC - Triple-Negative Breast CancerKorea, Republic of
-
Liaoning Tumor Hospital & InstituteNot yet recruitingTriple-negative Breast Cancer
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdult Solid Tumor | HER2-positive Breast Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative... and other conditionsUnited States
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Refractory Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)SuspendedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
Wuhan Union Hospital, ChinaRecruitingTriple-negative Breast Cancer | CadonilimabChina
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMetastatic Triple Negative Breast Cancer
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Cedars-Sinai Medical CenterCompletedBreast Cancer | Metastatic Triple NegativeUnited States
-
European Organisation for Research and Treatment...AstraZenecaWithdrawnBRCA1 Mutation | BRCA2 Mutation | TNBC - Triple-Negative Breast Cancer
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
Fondazione per la Medicina PersonalizzataUniversity of Roma La SapienzaRecruiting
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
University of WashingtonAbbVieNo longer availableTriple-Negative Breast Cancer | Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic MutationUnited States
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
Seoul National University HospitalActive, not recruitingHormone Receptor-positive Breast Cancer | Premenopausal Breast CancerKorea, Republic of
-
Yuan YuanGateway for Cancer Research; Agenus Inc.RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
OHSU Knight Cancer InstituteAstraZeneca; Oregon Health and Science UniversityRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
University Hospital, GrenobleRecruitingRadiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation | Intermediate and High-risk Luminal and Triple Negative Breast CancerFrance
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
M.D. Anderson Cancer CenterWithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Hormone Receptor Positive Breast Adenocarcinoma | Metastatic HER2 Negative Breast AdenocarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedEstrogen Receptor-positive Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingTriple-negative Breast Cancer and HR+/HER2- BCChina
-
Medical College of WisconsinRecruitingInvasive Breast CancerUnited States
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States, Spain, Belgium, Italy, France, Czechia, Poland
-
Vanderbilt University Medical CenterCompletedLung Diseases | Hypertension | Pulmonary Arterial Hypertension | Familial Primary Pulmonary Hypertension | Primary Pulmonary Hypertension | Estrogens | Tamoxifen | Estrogen Receptor Antagonist | Hormone AntagonistsUnited States
-
Celldex TherapeuticsNo longer availableMetastatic gpNMB Expressing Triple Negative Breast Cancer
-
Veronica Morgan JonesRecruitingBreast Cancer | Breast Carcinoma | HER2-negative Breast Cancer | Node-negative Breast CancerUnited States
-
ConcrRoyal Marsden NHS Foundation Trust; Institute of Cancer Research, United Kingdom and other collaboratorsEnrolling by invitationTriple Negative Breast Cancer | Cancer, Breast | Early-stage Breast CancerUnited Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI); Imugene LimitedActive, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
AC Camargo Cancer CenterH. Lee Moffitt Cancer Center and Research InstituteCompletedNeuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive TumorUnited States, Brazil
-
Gun Oh ChongNot yet recruitingHormone Receptor-positive Breast Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHormone Receptor-positive Breast Cancer